RASGRP3 and osteosarcoma: These reports of the involvement of these genes in the progression of other cancers led to the selection of the differentially activated PRKCε-RASGRP3-GNB2 network as a lead candidate for further characterization in osteosarcoma cells and tumors (Figure 5).